NIHR
Increased UK investment is driving HealthTech development
With significant investment bolstering the UK’s HealthTech R&D sector, NIHR can help companies to navigate all that the UK has to offer.
With the need to accelerate the digitisation of the NHS, shifting care from the hospital to the community, and a focus on disease prevention and early detection, the opportunities for HealthTech in the UK are significant. Now is the time to conduct research in the
NHS with the National Institute of Health and Care Research’s (NHR) support, as significant new investment building on an established and coordinated research ecosystem is perfectly placed to accelerate the development of HealthTech. The recently announced Voluntary Scheme
for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme will allocate £300 million to expand the UK’s capacity and capability for commercial clinical trials, targeting investment across health technology assessment and manufacturing. This will help to establish at least 15 new Commercial Research Delivery Centres across the UK supported by the NIHR. This is in addition to the £42 million investment
by NIHR to commission 14 HealthTech Research Centres which are already supporting companies to evaluate new innovations in the UK market. Combined with an improved and standardised
approach through the National Contract Value Review (NCVR), costing and contracting for commercial research has sped up following the successful application to late phase studies in Autumn 2023. Its usage has increased study set up time by around a third, and has now expanded to ATMPs and early phase studies.
NIHR’s free tailored support expedites HealthTech development in the UK Navigating the UK’s vast research infrastructure is vital to accelerate timelines to gain approvals quickly. Funded by the UK Government, NIHR invests
over £1.4 billion annually in research, resources, expertise, dedicated research facilities, and data platforms, all of which can support the life science industry to accelerate innovations into the NHS. The NIHR connects industry with the UK’s
leading research experts and HealthTech specialists, 16 UKHEALTHCARE P A VILION. COM DUB AI 2025
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
